Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2018, XLIV/259: 010-014 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2018, XLIV/259: 010-014

Title: Type and frequency of cardiac symptoms in patients with pulmonary sarcoidosis 

Authors: Błaut-Jurkowska J, Kaźnica-Wiatr M, Żygadło A, Lenart-Migalska A, Knap K, Tomkiewicz-Pająk L, Podolec P, Olszowska M. 

More details

02/259

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Type and frequency of cardiac symptoms in patients with pulmonary sarcoidosis


Błaut-Jurkowska J, Kaźnica-Wiatr M, Żygadło A, Lenart-Migalska A, Knap K, Tomkiewicz-Pająk L, Podolec P, Olszowska M.

Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Institute of Cardiology, John Paul II Hospital, Cracow, Poland


The aim of the study
was to assess the type and frequency of prevalence of cardiac symptoms in patients with pulmonary sarcoidosis.
Materials and methods
. The study group consisted of 54 patients (21 female, 33 male), with biopsy-proven pulmonary sarcoidosis. Mean age was 45.85 +/-11.77 years. According to time passed from diagnosis of sarcoidosis patients were divided into 2 subgroups. Additionally, age, sex, left ventricular ejection fraction, cigarette smoking and comorbidities were analyzed. Course and stage of sarcoidosis were also included in the analysis.
Results
. The frequency of cardiovascular symptoms in the study group was 87.04%. 59.26% of patients reported chest pain, the same subjects reported dyspnoea. 48.15% of respondents reported heart palpitations, 33.33% pre-syncope states, 12.96% syncope, and 37.04% edema of lower limbs. There were no statistically significant differences in the incidence of analyzed symptoms, depending on the duration of lung sarcoidosis.
Conclusion
. Patients with pulmonary sarcoidosis who report cardiovascular symptoms require further diagnostics.

Key words: sarcoidosis, cardiac symptoms, chest pain, dyspnoea

Pol Med J, 2018; XLIV (259); 10–14